SonoThera

About SonoThera

SonoThera is dedicated to developing the next generation of genetic medicines using ultrasound-mediated, nonviral technology to treat the root cause of human diseases. Their approach aims to overcome significant barriers in gene therapy such as safety, efficacy, biodistribution, and high costs.

Products & Services

Ultrasound-mediated Nonviral Genetic Medicine:A platform technology designed to overcome limitations in gene therapy by using ultrasound-mediated, nonviral methods for improved safety, efficacy, and biodistribution.

Specialties

Ultrasound-mediated genetic medicine Nonviral gene therapy Sonoporation

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series B T: - FT: Series B	A: 125000000 MR: - FA: 125M FAN: 125000000	D: 2026-01-08 FD: 2026-01-08	-

Series B Latest

2026-01-08

$125.0M

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

M

Marco Crosariol

VP, Operations

S

Steve Feinstein

Chief Scientific Officer

K

Kenneth Greenberg

Chief Executive Officer

S

Shawn Fu

VP Corporate Development & Strategy

N

Nancy Jorgesen

SVP, Product Development

I

Ivan Krivega, PhD

VP, Gene Therapy

View 58 more team members with Pro

Unlock Full Team Directory

Recent News

SonoThera Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised